Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences Corp (EW), sold 17,220 shares at $64.68 ($1.1M) on 2023-11-13, disclosed to the SEC on 2023-11-13.
Scheduled sale ($1.1M) by Global President TAVR & Surg under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.68 | 3,158 | $204K | 18.2% |
| 2 | $64.68 | 3,158 | $204K | 18.2% |
| 3 | $65.64 | 5,402 | $355K | 31.5% |
| 4 | $65.64 | 5,402 | $355K | 31.5% |
| 5 | $66.21 | 100 | $7K | 0.6% |
| Total | $65.29 avg | 17,220 |
| $1.1M |
| 100% |
| Filing → |
| EW | SELL | 2025-06-16 | $1.3M | — | Filing → |
| EW | SELL | 2024-11-05 | $1.6M | — | Filing → |
| EW | SELL | 2023-12-13 | $1.2M | — | Filing → |